In this issue:
Which patients with mHSPC derive the most benefit from docetaxel?
ASCO guideline update: Initial management of noncastrate prostate cancer
Coffee may protect against cancer-specific mortality in some patients
Long-term outcomes of HDR brachytherapy in favourable localised disease
Better survival in Asian men with prostate cancer
PANTHER: Efficacy of AAAP for mCRPC varies by race
Addition of EBRT to brachytherapy for intermediate-risk disease
Recurrence risk can be predicted using pre-prostatectomy MRI
Nanoparticle encapsulated prodrug may overcome treatment-resistance
Salvage cryoablation following primary EBRT or cryotherapy
Genetic testing station feasible for germline testing
Prostate Cancer Patient Voices website launched
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)